Brief: Biomarin To Acquire Inozyme Pharma
16/05/2025 12:38
May 16 (Reuters) - Biomarin Pharmaceutical Inc BMRN.O: BIOMARIN STRENGTHENS ENZYME THERAPY BUSINESS WITH ACQUISITION OF INOZYME PHARMA INOZYME PHARMA INC - BIOMARIN TO BUY INOZYME FOR $270 MILLION INOZYME PHARMA INC - BIOMARIN REAFFIRMS 2025 FINANCIAL GUIDANCE Source text: ID:nPn7HZbjva Further company coverage: BMRN.O
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin